Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

FDA Clears Novel Alzheimer's Blood Test

(MedPage Today) -- The FDA cleared the PrecivityAD2 blood test to help diagnose Alzheimer's disease as part of a standard clinical workup, C2N Diagnostics announced Thursday. The test, which measures plasma amyloid beta and tau peptide ratios...

FDA Clears Novel Alzheimer's Blood Test

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Friday 21 August →